Michel Coleman

Michel Coleman is a Professor of Epidemiology and Vital Statistics at the London School of Hygiene and Tropical Medicine (LSHTM), where he has led the Cancer Survival Group since 1995. His work focuses on cancer incidence, mortality, and survival disparities across socioeconomic, geographic, and ethnic groups, with applications to public health policy. He co-directs LSHTM's annual short course on "Cancer survival: principles, methods and applications" and supervises doctoral students.

• Academic Background: BA (Oxford, 1971), BM BCh (Oxford, 1975), MSc Epidemiology (LSHTM, 1981), MFCM (1985), FFPH (2006)
• Professional Roles: Honorary Consultant in Oncology (UCL Hospitals NHS), Visiting Professor (Newcastle University), Cybersecurity Forum member (LSHTM)

His research drives the CONCORD program, a series of global cancer survival studies spanning 31 countries (CONCORD-1, 1999) to 71 countries (CONCORD-3, 2018) and 350+ registries in CONCORD-4 (2023–2025). This includes analyzing 90 million adult and 650,000 pediatric cancer cases to assess 30-year survival trends and pandemic impacts.

Scientific recognition includes the Calum S. Muir Memorial Award (2018) for advancing cancer registry capacity and training. Current grants from St Jude Children’s Research Hospital, Cancer Research UK, and Institut National Du Cancer fund ongoing CONCORD-4 work. His team collaborates with 720 CONCORD Working Group members and 25 Lancet Global Commission colleagues.